1. Home
  2. SMID vs CMPX Comparison

SMID vs CMPX Comparison

Compare SMID & CMPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SMID
  • CMPX
  • Stock Information
  • Founded
  • SMID 1960
  • CMPX 2014
  • Country
  • SMID United States
  • CMPX United States
  • Employees
  • SMID N/A
  • CMPX N/A
  • Industry
  • SMID Building Materials
  • CMPX Biotechnology: Pharmaceutical Preparations
  • Sector
  • SMID Industrials
  • CMPX Health Care
  • Exchange
  • SMID Nasdaq
  • CMPX Nasdaq
  • Market Cap
  • SMID 163.4M
  • CMPX 217.4M
  • IPO Year
  • SMID 1995
  • CMPX N/A
  • Fundamental
  • Price
  • SMID $33.18
  • CMPX $1.54
  • Analyst Decision
  • SMID
  • CMPX Strong Buy
  • Analyst Count
  • SMID 0
  • CMPX 2
  • Target Price
  • SMID N/A
  • CMPX $9.00
  • AVG Volume (30 Days)
  • SMID 36.9K
  • CMPX 370.5K
  • Earning Date
  • SMID 11-07-2024
  • CMPX 11-07-2024
  • Dividend Yield
  • SMID N/A
  • CMPX N/A
  • EPS Growth
  • SMID N/A
  • CMPX N/A
  • EPS
  • SMID 0.87
  • CMPX N/A
  • Revenue
  • SMID $68,434,000.00
  • CMPX $850,000.00
  • Revenue This Year
  • SMID N/A
  • CMPX N/A
  • Revenue Next Year
  • SMID N/A
  • CMPX $950.68
  • P/E Ratio
  • SMID $41.48
  • CMPX N/A
  • Revenue Growth
  • SMID 26.77
  • CMPX N/A
  • 52 Week Low
  • SMID $17.36
  • CMPX $0.77
  • 52 Week High
  • SMID $48.87
  • CMPX $2.34
  • Technical
  • Relative Strength Index (RSI)
  • SMID 54.81
  • CMPX 64.03
  • Support Level
  • SMID $29.71
  • CMPX $1.42
  • Resistance Level
  • SMID $32.00
  • CMPX $1.65
  • Average True Range (ATR)
  • SMID 2.17
  • CMPX 0.13
  • MACD
  • SMID -0.08
  • CMPX 0.01
  • Stochastic Oscillator
  • SMID 59.54
  • CMPX 66.01

About SMID Smith-Midland Corporation

Smith-Midland Corp through its subsidiaries invents, develops, manufactures, markets, sells, and installs precast concrete products for primary use in the construction, highway, utilities, and farming industries. The firm's customers are general contractors and federal, state, and local transportation authorities. Its products include Slenderwall, JJhooks, Softsound, Sierra Wall and Easi set. A substantial portion of the company's business is derived from local, state, and federal building projects. The company generates revenues predominantly from the sale, leasing, licensing, shipping, and installation of precast concrete products for the construction, utility, and farming industries.

About CMPX Compass Therapeutics Inc.

Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics intended to engage the immune system to treat both solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to broadly drug the immune system and identify optimal combinations empirically. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of three product candidates, CTX-009, CTX-471, and CTX-8371.

Share on Social Networks: